Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
-0.48%
SPX
-0.32%
IXIC
-0.03%
FTSE
-0.09%
N225
+1.03%
AXJO
+0.51%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Overview

Loading chart...
Join our newsletter to keep up to date with us!

Key Stats

Market Cap
3.25B
Dividend Yield
0.00%
P/E Ratio
-79.90
EPS
-2.50
Revenue
398.99M
Avg. Volume
670.26K

Recently from Cashu

publisher logo
Cashu

Zai Lab and Amgen's Bemarituzumab Trial Aims to Transform Gastric Cancer Treatment

about 1 hour ago
publisher logo
Cashu

Oncolytics Advances Pelareorep Immunotherapy, Boosting Prospects for Zai Lab in Oncology Market

1 day ago
publisher logo
Cashu

Zai Lab Positioned for Growth Amid Oncolytics' Immunotherapy Advancements in Pancreatic Cancer

3 days ago

About

What does ZLAB do?
It seems that there is no content provided for summarization. Please provide the text you would like summarized.
Sector
💻 Health Care
IPO
CEO
Employees
1,194
Headquarters
China
Website
http://www.zailaboratory.com
Stocks
Health Care
zlab
Zai Lab
HONG KONG EXCHANGES AND CLEARING LTD: ZLAB
+0.77 (+2.57%)
30.77
USD
At close at Sep 05, 20:42 UTC
Summary
News
Signals
Benchmarks
Financials